2007
DOI: 10.1016/j.clinph.2007.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Sensory integration in writer’s cramp: Comparison with controls and evaluation of botulinum toxin effect

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
14
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 37 publications
2
14
0
Order By: Relevance
“…In line with previous studies [7], [32], [38], the present study shows normal N20m and P35m responses in patients with WC. SEFs represent the responses of cortical neurons to changes in afferent activity [39].…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…In line with previous studies [7], [32], [38], the present study shows normal N20m and P35m responses in patients with WC. SEFs represent the responses of cortical neurons to changes in afferent activity [39].…”
Section: Discussionsupporting
confidence: 93%
“…Neruoimaging studies have shown normal electrophysiological processes in patients with dystonia [7], [32], [38]. In line with previous studies [7], [32], [38], the present study shows normal N20m and P35m responses in patients with WC.…”
Section: Discussionsupporting
confidence: 92%
“…We also conclude that other cortical (pre-SMA, DLPFC) and subcortical areas (left lateral cerebellum) play a less prominent role in the STDT than S1. This new information giving further insight into the mechanisms involved in temporal discrimination of tactile stimuli – as tested with the STDT- in healthy subjects – helps interpret the sensory processing deficits in neurological diseases such as focal dystonia and Parkinson's disease and possibly prompts future studies applying TBS over S1 for therapeutic purposes in dystonic patients [15][18].…”
Section: Discussionmentioning
confidence: 91%
“…Several randomized, double-blind, controlled studies in limb dystonia have been performed investigating abobotulinumtoxinA (128, 129) and onabotulinumtoxinA (130132). When comparing these studies, outcome measures and populations enrolled have marked variability.…”
Section: Therapymentioning
confidence: 99%